Skip to main content

Table 8 Survival analysis of three treatments on five BIC subtypes

From: Subtype identification from heterogeneous TCGA datasets on a genomic scale by multi-view clustering with enhanced consensus

Treatment All Subtype 1 Subtype 2 Subtype 3 Subtype 4 Subtype 5
Cytoxan 3.29e-2 1.98e-5 4.94e-2 0.310 0.447 0.226
Adriamycin 1.32e-2 1.24e-3 0.646 0.892 0.095 0.760
Arimidex 0.19 0.654 0.607 1.82e-2 0.433 0.352
  1. The treatment could generate significantly improved treatment effects in the subtype of p-value in boldface